JARRETT v. WRIGHT MEDICAL TECHNOLOGY, INC.

CourtDistrict Court, S.D. Indiana
DecidedMarch 26, 2021
Docket1:12-cv-00064
StatusUnknown

This text of JARRETT v. WRIGHT MEDICAL TECHNOLOGY, INC. (JARRETT v. WRIGHT MEDICAL TECHNOLOGY, INC.) is published on Counsel Stack Legal Research, covering District Court, S.D. Indiana primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
JARRETT v. WRIGHT MEDICAL TECHNOLOGY, INC., (S.D. Ind. 2021).

Opinion

UNITED STATES DISTRICT COURT SOUTHERN DISTRICT OF INDIANA INDIANAPOLIS DIVISION

COLEMAN JARRETT, et al. ) ) Plaintiffs, ) ) v. ) No. 1:12-cv-00064-SEB-DML ) WRIGHT MEDICAL TECHNOLOGY, INC., ) ) Defendant. )

ORDER ON MOTIONS TO EXCLUDE EXPERT TESTIMONY

Plaintiffs Coleman and Paula Jarrett commenced this action in 2012 as part of a multidistrict litigation styled "CONSERVE® Hip Implant Product Liability Litigation, MDL 2329," pending before the United States District Court for the Northern District of Georgia. This case, relating to Mr. Jarrett's receipt of hip implant components from Defendant Wright Medical Technology Inc.'s ("Wright Medical") CONSERVE® product line during a July 17, 2006 left total hip arthroplasty, was remanded and transferred to our court to proceed individually on July 6, 2018. Plaintiffs allege that, based on purported defects in the CONSERVE® devices generally relating to alleged design defects that Plaintiffs claim caused excessive metal ion release and loosening of the CONSERVE® Cup device, Mr. Jarrett was forced to undergo a second "revision" surgery on July 12, 2010 to remove the CONSERVE® devices. Now before the Court are Defendant's Motions to Exclude the Expert Testimony of John I. Waldrop, M.D. [Dkt. 80] and John D. Jarrell, Ph.D., PE [Dkt. 81], who have been retained by Plaintiffs to testify regarding the alleged propensity of the metal-on- metal design of the CONSERVE® products to generate high levels of metal ion release allegedly resulting in the loosening and early failure of the implant. Defendant moves,

pursuant to Federal Rules of Evidence 702 and 703 and Daubert v. Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579 (1993), to exclude the expert testimony of Drs. Waldrop and Jarrell on various grounds. Plaintiffs oppose these motions. For the reasons detailed below, we GRANT IN PART and DENY IN PART Defendant's Motions to Exclude.

Applicable Legal Standard The admissibility of expert testimony is governed by the framework set out in Federal Rule of Evidence 702 and Daubert v. Merrell Dow Pharms. Inc., 509 U.S. 579 (1993). Lewis v. CITGO Petroleum Corp., 561 F.3d 698, 705 (7th Cir. 2009). Applying

this framework, courts must undertake: a three-step analysis: the witness must be qualified "as an expert by knowledge, skill, experience, training, or education"; the expert's reasoning or methodology underlying the testimony must be scientifically reliable; and the testimony must assist the trier of fact to understand the evidence or determine a fact in issue. Ervin v. Johnson & Johnson, Inc., 492 F.3d 901, 904 (7th Cir. 2007) (quoting Fed. R. Evid. 702) (internal citations omitted); see also Kumho Tire Co., Ltd. v. Carmichael, 526 U.S. 137, 141 (1999) (extending the Daubert admissibility framework to expert testimony in the social sciences). “The Daubert standard applies to all expert testimony, whether it relates to an area of traditional scientific competence or whether it is founded on engineering principles or other technical or specialized expertise.” Smith v. Ford Motor Co., 215 F.3d 713, 719 (7th Cir. 2000) (citing Kumho, 536 U.S. at 141). The burden is on the proponent of the expert to demonstrate that the expert's testimony would

satisfy the Daubert standard. Lewis, 561 F.3d 705. Discussion I. Expert Testimony of Dr. Waldrop

John I. Waldrop, M.D. is an orthopedic surgeon whom Plaintiffs have identified as an expert to offer opinions concerning "the implantation and failure of the Wright Medical CONSERVE® Total Hip Implant Device associated with" Mr. Jarrett. Waldrop Rep. at 1. Dr. Waldrop has been practicing medicine for 40 years, maintaining an active practice performing hip and knee arthroplasties. He estimates that he has performed more than 5,000 to 6,000 total hip procedures and, since 2010, has revised 64 hips, many

of which were metal-on-metal implants, including five to ten CONSERVE® devices. Dr. Waldrop's general causation report discusses five general "characteristics" of metallosis1 caused by metal-on-metal hip implants that he has observed in his practice:

(1) discolored fluid in the joint; (2) "death or necrosis of local tissue in the hip area"; (3) "cystic responses" or pseudotumors; (4) other tissue reactions including inflammation, discoloration, and staining; and (5) elevated cobalt and chromium levels. His expert report includes photographs of hip replacement revision surgeries involving ten unidentified patients from his practice, none of whom is Mr. Jarrett. There is no

1 Metallosis is a blood poisoning condition that develops as a result of having high levels of toxic metals in the blood. information included in Dr. Waldrop's report regarding the manufacturer of the hip implant components depicted in the photographs, the medical backgrounds of the

patients, the implanting surgeons, or any other background information regarding the surgeries. Dr. Waldrop testified that he is "[p]retty sure at least one" of the devices depicted in the photographs is a Wright Medical CONSERVE® device, but that he is unable to identify which of the depicted devices were manufactured by Wright Medical. Waldrop Dep. at 67–68.

With regard to Mr. Jarrett's case specifically, Dr. Waldrop states that he "examined the medical records of Coleman Jarrett including digital x-rays of his prothesis," and based on his review of these materials and his education, training, and experience, he has formed the opinion that the failure of Mr. Jarrett's CONSERVE® total hip implant "was

due to the pain associated with metallosis, corrosion, and component loosening associated with metal-on-metal hip failures," that the findings during Mr. Jarrett's revision surgery "including the noted pseudotumor, corrosion, and other indicative findings of a metallosis reaction are consistent with [his] own clinical findings on revision of metal-on-metal prosthesis," and that Mr. Jarrett's "pain prior to the revision,

necessity of the revision, and injuries after the revision are the result of the defective metal-on-metal prosthesis." Dr. Waldrop further opines that Mr. Jarrett likely will experience future injuries, including the potential for an additional revision surgery, and that the medical billing for Mr. Jarrett's July 12, 2010 revision surgery was reasonable. Wright Medical seeks to have Dr. Waldrop's general and specific causation opinions excluded because "they are not scientifically derived or based on any

reproducible test, and [they] lack fit with this case." Dkt. 82 at 1. Additionally, Wright Medical argues that Dr. Waldrop's testimony regarding Mr. Jarrett's potential future injuries is too speculative to be admissible and that his testimony regarding the reasonableness of Mr. Jarrett's medical bills should be excluded because he lacks any special knowledge in the area of billing to support such an opinion. We address these arguments in turn below.

A. General Causation Opinions

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Daubert v. Merrell Dow Pharmaceuticals, Inc.
509 U.S. 579 (Supreme Court, 1993)
Kumho Tire Co. v. Carmichael
526 U.S. 137 (Supreme Court, 1999)
Myers v. Illinois Central Railroad
629 F.3d 639 (Seventh Circuit, 2010)
Mark A. Smith v. Ford Motor Company
215 F.3d 713 (Seventh Circuit, 2000)
Shirley A. Lang v. Kohl's Food Stores, Inc.
217 F.3d 919 (Seventh Circuit, 2000)
Clyde Ammons v. Aramark Uniform Services, Inc.
368 F.3d 809 (Seventh Circuit, 2004)
Lewis v. Citgo Petroleum Corp.
561 F.3d 698 (Seventh Circuit, 2009)
Ervin v. Johnson & Johnson, Inc.
492 F.3d 901 (Seventh Circuit, 2007)
Christiansen v. Wright Medical Technology Inc.
127 F. Supp. 3d 1306 (N.D. Georgia, 2015)
In re Mirena IUD Products Liability Litigation
169 F. Supp. 3d 396 (S.D. New York, 2016)
Higgins v. Koch Development Corp.
997 F. Supp. 2d 924 (S.D. Indiana, 2014)

Cite This Page — Counsel Stack

Bluebook (online)
JARRETT v. WRIGHT MEDICAL TECHNOLOGY, INC., Counsel Stack Legal Research, https://law.counselstack.com/opinion/jarrett-v-wright-medical-technology-inc-insd-2021.